Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Thomson Reuters StreetEvents
$75.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

T2 Biosystems Inc announces closing of initial public offering


Tuesday, 12 Aug 2014 01:00pm EDT 

T2 Biosystems Inc:Closes initial public offering of 5,980,000 shares of common stock at an initial public offering price of $11.00 per share, which includes exercise in full by the underwriters of their option to purchase up to 780,000 additional shares of common stock.Shares began trading on NASDAQ Global Market under ticker symbol TTOO on Aug. 07.All of shares in offering were offered by company.Goldman, Sachs & Co. and Morgan Stanley acted as joint book-running managers for the offering.Leerink Partners and Janney Montgomery Scott acted as co-managers.A registration statement relating to these securities was declared effective by Securities and Exchange Commission on Aug. 6. 

Company Quote

16.59
1.28 +8.36%
21 Nov 2014